Log In
Print
BCIQ
Print
Print this Print this
 

BreathTek UBT

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionTest that determines the ratio of carbon-13 dioxide (13CO2) to 12CO2 by infrared spectrophotometer in a breath sample following ingestion of pranactin-citric solution, which contains carbon-13 urea
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose Helicobacter pylori infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today